- recruitingPHASE2, PHASE3
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
This study is looking at a new medicine called R-DXd for certain types of advanced ovarian, primary peritoneal, or fallopian tube cancer that haven't responded well to platinum chemotherapy. It aims to find out if R-DXd is safe and effective.
United States · Australia · Brazil - recruitingNA
Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors
This study is looking at how a natural substance called Urolithin A might help the immune system of people with certain cancers who are having a type of treatment called immune checkpoint inhibitors. Some get Urolithin A, others get a dummy pill.
Germany